Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Wisløff

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
European Journal of Haematology|August 1, 1997
Survival in 86 patients, aged 15-60, with primary acute myelogenous leukemia, treated with a common program in the Norwegian health regions I, III, IV and V in the period 1990-1995J M Tangen, M Abdelnoor, L Brinch, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 18, 2001
[High dose therapy with autologous stem cell support--finally a progress in myelomatosis]F Wisløff, J M Tangen, L Brinch, et al.
European Journal of Haematology|November 1, 1991
Incidence and follow-up of asymptomatic multiple myeloma. The myeloma project of health region I in Norway. IIF Wisløff, P Andersen, T R Andersson, et al.
European Journal of Haematology|November 1, 1991
Has the incidence of multiple myeloma in old age been underestimated? The myeloma project of health region I in Norway. IF Wisløff, P Andersen, T R Andersson, et al.
British Journal of Haematology|March 23, 1999
Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of LifeM L Stead, J M Brown, G Velikova, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2007
An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myelomaK Cocks, D Cohen, F Wisløff, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell supportN Gulbrandsen, F Wisløff, L Brinch, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
European Journal of Haematology|August 1, 1997
Survival in 86 patients, aged 15-60, with primary acute myelogenous leukemia, treated with a common program in the Norwegian health regions I, III, IV and V in the period 1990-1995J M Tangen, M Abdelnoor, L Brinch, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 18, 2001
[High dose therapy with autologous stem cell support--finally a progress in myelomatosis]F Wisløff, J M Tangen, L Brinch, et al.
European Journal of Haematology|November 1, 1991
Incidence and follow-up of asymptomatic multiple myeloma. The myeloma project of health region I in Norway. IIF Wisløff, P Andersen, T R Andersson, et al.
European Journal of Haematology|November 1, 1991
Has the incidence of multiple myeloma in old age been underestimated? The myeloma project of health region I in Norway. IF Wisløff, P Andersen, T R Andersson, et al.
British Journal of Haematology|March 23, 1999
Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of LifeM L Stead, J M Brown, G Velikova, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2007
An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myelomaK Cocks, D Cohen, F Wisløff, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell supportN Gulbrandsen, F Wisløff, L Brinch, et al.
Pageof 9